New England Capital Financial Advisors’s Quest Diagnostics DGX Stock Holding History

New England Capital Financial Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.1K	Hold	312	–	–	0.02%	118
2026 Q1	$61.1K	Hold	312	–	–	0.02%	117
2025 Q4	$54.1K	Sell	312 -79	-20%	-$14.4K	0.02%	129
2025 Q3	$74.6K	Hold	391	–	–	0.03%	98
2025 Q2	$70.2K	Hold	391	–	–	0.03%	94
2025 Q1	$66.1K	Buy	391 +1	+0.3%	+$164	0.03%	97
2024 Q4	$58.9K	Hold	390	–	–	0.03%	108
2024 Q3	$60.5K	Buy	390 +1	+0.3%	+$149	0.03%	102
2024 Q2	$53.3K	Hold	389	–	–	0.03%	105
2024 Q1	$51.8K	Buy	389 +77	+25%	+$9.99K	0.03%	107
2023 Q4	$43K	Hold	312	–	–	0.03%	120
2023 Q3	$38K	Hold	312	–	–	0.03%	121
2023 Q2	$43.9K	Hold	312	–	–	0.03%	121
2023 Q1	$44.1K	Hold	312	–	–	0.03%	126
2022 Q4	$45.4K	Buy	+312	New	+$44.8K	0.03%	126

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

New England Capital Financial Advisors's DGX Position: Q2 2026 in Review

New England Capital Financial Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 312 shares worth $66.1K. The position accounts for 0.02% of the portfolio, ranked #118.

New England Capital Financial Advisors first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. The position peaked at $74.6K in Q3 2025. 766 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

New England Capital Financial Advisors held 312 shares of Quest Diagnostics worth $66.1K as of Q2 2026.
New England Capital Financial Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.02% of New England Capital Financial Advisors's portfolio in Q2 2026, its #118 holding.
New England Capital Financial Advisors first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
New England Capital Financial Advisors's Quest Diagnostics position peaked at $74.6K in Q3 2025.
766 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.